BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9411770)

  • 1. Dopamine role.
    Sarter M; Bruno JP
    Science; 1997 Nov; 278(5343):1549-50. PubMed ID: 9411770
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine and drug addiction: the nucleus accumbens shell connection.
    Di Chiara G; Bassareo V; Fenu S; De Luca MA; Spina L; Cadoni C; Acquas E; Carboni E; Valentini V; Lecca D
    Neuropharmacology; 2004; 47 Suppl 1():227-41. PubMed ID: 15464140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence.
    Di Chiara G; Tanda G; Cadoni C; Acquas E; Bassareo V; Carboni E
    Adv Pharmacol; 1998; 42():983-7. PubMed ID: 9328062
    [No Abstract]   [Full Text] [Related]  

  • 4. Forebrain dopaminergic-cholinergic interactions, attentional effort, psychostimulant addiction and schizophrenia.
    Sarter M; Bruno JP; Parikh V; Martinez V; Kozak R; Richards JB
    EXS; 2006; 98():65-86. PubMed ID: 17019883
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of nucleus accumbens dopaminergic transmission in acoustic startle: observations concerning prepulse inhibition in rats with entorhinal cortex lesions.
    Goto K; Ueki A; Iso H; Morita Y
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):441-5. PubMed ID: 15298660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways.
    Wolf ME
    Mol Interv; 2002 Jun; 2(3):146-57. PubMed ID: 14993375
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for schizophrenia--all roads lead to dopamine.
    Di Forti M; Lappin JM; Murray RM
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S101-7. PubMed ID: 17336764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF; Segovia G; Mora F
    Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug motivation and abuse: a neurobiological perspective.
    Di Chiara G; Acquas E; Carboni E
    Ann N Y Acad Sci; 1992 Jun; 654():207-19. PubMed ID: 1632584
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system.
    Self DW
    Neuropharmacology; 2004; 47 Suppl 1():242-55. PubMed ID: 15464141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine in the accumbens is decreased by diazepam and increased by benzodiazepine withdrawal: a possible mechanism for dependency.
    Rada P; Hoebel BG
    Eur J Pharmacol; 2005 Jan; 508(1-3):131-8. PubMed ID: 15680263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptors in the nucleus accumbens modulate dopamine-dependent but not acetylcholine-dependent turning behaviour of rats.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Neuroscience; 2009 Mar; 159(3):974-81. PubMed ID: 19356681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mouse brain slice preparation of the hippocampo-accumbens pathway.
    Matthews RT; Coker O; Winder DG
    J Neurosci Methods; 2004 Aug; 137(1):49-60. PubMed ID: 15196826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P depresses excitatory synaptic transmission in the nucleus accumbens through dopaminergic and purinergic mechanisms.
    Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
    J Neurophysiol; 2003 Feb; 89(2):728-37. PubMed ID: 12574450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
    Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
    Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational roles for dopamine in behavioural control.
    Montague PR; Hyman SE; Cohen JD
    Nature; 2004 Oct; 431(7010):760-7. PubMed ID: 15483596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine receptor effects on accumbal shell dopamine-mediated turning behaviour in rats.
    Moribe S; Ikeda H; Sato M; Akiyama G; Matsuzaki S; Hasegawa K; Koshikawa N; Cools AR
    Neuropharmacology; 2005 Sep; 49(4):514-24. PubMed ID: 15935407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex.
    Del Arco A; Mora F
    Pharmacol Biochem Behav; 2008 Aug; 90(2):226-35. PubMed ID: 18508116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.